MDxHealth SA
MDXH
$3.51
$0.113.09%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 27.53% | 20.50% | 32.33% | 34.93% | 50.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.53% | 20.50% | 32.33% | 34.93% | 50.48% |
| Cost of Revenue | 37.09% | 33.03% | 31.35% | 29.84% | 18.70% |
| Gross Profit | 22.46% | 13.72% | 32.99% | 38.42% | 75.40% |
| SG&A Expenses | 2.34% | 13.25% | 12.32% | 7.84% | 13.03% |
| Depreciation & Amortization | -70.40% | 17.64% | -49.84% | 0.09% | 41.81% |
| Other Operating Expenses | 328.50% | 8.33% | 31.03% | -101.24% | -183.19% |
| Total Operating Expenses | 14.17% | 22.99% | 19.79% | 12.90% | 15.65% |
| Operating Income | 26.93% | -33.57% | 7.34% | 24.24% | 32.45% |
| Income Before Tax | 36.63% | -7.96% | -8.49% | 27.31% | 12.92% |
| Income Tax Expenses | 4,700.00% | -- | -- | -- | -99.22% |
| Earnings from Continuing Operations | 36.18% | -11.39% | -8.49% | 27.31% | 13.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.18% | -11.39% | -8.49% | 27.31% | 13.81% |
| EBIT | 26.93% | -33.57% | 7.34% | 24.24% | 32.45% |
| EBITDA | 48.88% | -46.29% | 9.89% | 33.57% | 39.24% |
| EPS Basic | 64.10% | -8.11% | -1.47% | 41.51% | 49.66% |
| Normalized Basic EPS | 108.71% | -- | 23.66% | -- | 89.90% |
| EPS Diluted | 64.10% | -8.11% | -1.47% | 41.51% | 49.66% |
| Normalized Diluted EPS | 108.71% | -- | 23.66% | -- | 89.90% |
| Average Basic Shares Outstanding | 77.77% | 3.03% | 6.92% | 24.27% | 71.21% |
| Average Diluted Shares Outstanding | 77.77% | 3.03% | 6.92% | 24.27% | 71.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |